Dr. Jonathan Schwartz
Institution Name:
Total Awards:
1
Award Value:
$5,808,735
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Rocket Pharmaceuticals, Inc. | A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease | $5,808,735 |
| Total: $5,808,735.00 |